Short-term Prognosis in Liver Transplantation Perioperative Period with the Use of Synbiotics: An Observational Study

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-jRCT1050240166

Enrollment

Registered

2024-10-22

Start date

2024-09-30

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

end stage liver failure

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who are 18 years of age or older at the time of informed consent Cases who were clinically diagnosed as being suitable for liver transplantation and underwent living donor liver transplantation after the date of approval for this study.

Exclusion criteria

Exclusion criteria: Patients who have difficulty in oral intake Patients with lactose allergy

Design outcomes

Primary

Measure	Time frame
Presence or absence of infection: Wound infection, cholangitis, pneumonia, urinary tract infection, intra-abdominal infection, sepsis, catheter infection, etc.	—

Secondary

Measure	Time frame
Complications grade II or higher based on Clavien-Dindo classification Postoperative liver damage (AST, ALT values) Series of reactions (based on liver biopsy) Early graft dysfunction (EAD) Defecation frequency/characteristics of stool	—

Contacts

Public ContactYoichiro Uchida

Department of Surgery, Graduate School of Medicine, Kyoto University

uchiday@kuhp.kyoto-u.ac.jp+81-75-751-4323

Outcome results